相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional characterization of 84 PALB2 variants of uncertain significance
Timothy Wiltshire et al.
GENETICS IN MEDICINE (2020)
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Heng Zhu et al.
MOLECULAR CANCER (2020)
Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines
Sean Tavtigian et al.
HUMAN MUTATION (2020)
Novel RNA and DNA strand exchange activity of the PRLB2 DNA binding domain and its critical role for DNA repair in cells
Jaigeeth Deveryshetty et al.
ELIFE (2019)
Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2
Amethyst Saldia et al.
CANCER PREVENTION RESEARCH (2019)
A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor
Amelie Rodrigue et al.
NUCLEIC ACIDS RESEARCH (2019)
Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
Rick A. C. M. Boonen et al.
NATURE COMMUNICATIONS (2019)
The Tumor Suppressor PALB2: Inside Out
Mandy Ducy et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials
Dalia Kamel et al.
CURRENT DRUG TARGETS (2018)
Biomarkers for Homologous Recombination Deficiency in Cancer
Michal M. Hoppe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Biomarkers for Homologous Recombination Deficiency in Cancer
Michal M. Hoppe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function
Lea M. Starita et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Accurate classification of BRCA1 variants with saturation genome editing
Gregory M. Findlay et al.
NATURE (2018)
DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment
Amanda Ewart Toland et al.
JOURNAL OF MEDICAL GENETICS (2017)
Coupling of Homologous Recombination and the Checkpoint by ATR
Remi Buisson et al.
MOLECULAR CELL (2017)
Compromised BRCA1-PALB2 interaction is associated with breast cancer risk
T. K. Foo et al.
ONCOGENE (2017)
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
Jie Sun et al.
CLINICAL CANCER RESEARCH (2017)
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
Shih-Hung Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M. Norquist et al.
JAMA ONCOLOGY (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
David B. Zhen et al.
GENETICS IN MEDICINE (2015)
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls
Ella R. Thompson et al.
BREAST CANCER RESEARCH (2015)
PALB2: The hub of a network of tumor suppressors involved in DNA damage responses
Jung-Young Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair
J-Y Park et al.
ONCOGENE (2014)
Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
Ana Blanco et al.
PLOS ONE (2013)
Novel germline PALB2 truncating mutations in African American breast cancer patients
Yonglan Zheng et al.
CANCER (2012)
MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination
Fan Zhang et al.
JOURNAL OF CELL SCIENCE (2012)
PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function
Jianglin Ma et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
PALB2 mutations in familial breast and pancreatic cancer
Erin W. Hofstatter et al.
FAMILIAL CANCER (2011)
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes
Mohammad R. Akbari et al.
JOURNAL OF MEDICAL GENETICS (2011)
PALB2 mutations in European familial pancreatic cancer families
E. P. Slater et al.
CLINICAL GENETICS (2010)
Allergies, obesity, other risk factors and survival from pancreatic cancer
Sara H. Olson et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks
Tomohiro Hayakawa et al.
JOURNAL OF CELL SCIENCE (2010)
Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination
Remi Buisson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2
Eloiese Dray et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Feng Zhang et al.
CURRENT BIOLOGY (2009)
Structural basis for recruitment of BRCA2 by PALB2
Antony W. Oliver et al.
EMBO REPORTS (2009)
Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
Suhwan Chang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
Fan Zhang et al.
MOLECULAR CANCER RESEARCH (2009)
A role for monoubiquitinated FANCD2 at telomeres in ALT cells
Qiang Fan et al.
NUCLEIC ACIDS RESEARCH (2009)
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Shirley M. H. Sy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
Sequence Variant Classification and Reporting: Recommendations for Improving the Interpretation of Cancer Susceptibility Genetic Test Results
Sharon E. Plon et al.
HUMAN MUTATION (2008)
Clinically Applicable Models to Characterize BRCA1 and BRCA2 Variants of Uncertain Significance
Andrew D. Spearman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Analysis of PALB2/FANCN-associated breast cancer families
Marc Tischkowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A recurrent mutation in PALB2 in Finnish cancer families
Hannele Erkko et al.
NATURE (2007)
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Bing Xia et al.
NATURE GENETICS (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance
G Chenevix-Trench et al.
CANCER RESEARCH (2006)
Human fanconi anemia monoubiquitination pathway promotes homologous DNA repair
K Nakanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
